Navigation Links
American Chemical Society calls green chemistry bill a 'smart step'
Date:9/5/2007

WASHINGTON, D.C., Sept. 5, 2007 The American Chemical Society (ACS) today praised House passage of legislation seeking to improve federal coordination, dissemination and investment in green chemistry research and development (R&D). The Green Chemistry Research and Development Act of 2007 (HR 2850) aims to provide safer, more sustainable technological options to replace traditional products and processes.

H.R. 2850 was introduced in the House on June 25, 2007, by Reps. Phil Gingrey (R-Ga.), Mario Diaz-Balart (R-Fla.), Vernon Ehlers (R-Mich.), Peter Welch (D-Vt.), and David Wu (D-Ore.). On July 11, 2007, the House Committee on Science and Technology passed the bill by unanimous consent, and the bill yesterday passed the full House of Representatives by voice vote. Similar legislation was passed overwhelmingly by the House in each of the last two Congresses, but was not acted on in the Senate.

Green chemistry is the ultimate proof that environmental and economic benefits in chemistry can be optimized simultaneously. The technologies that spin out of this novel research are the seeds that can sustain small business ventures and green corporate practices, said Catherine T. Hunt, Ph.D., ACS President. From reducing and improving pharmaceutical processes, reinventing the home and construction business, to over-coming our climate and energy challenges, green chemistry is proving that economics and environment are not mutually exclusive.

The bill dedicates resources at a number of federal agencies towards green chemistry R&D and improves interagency coordination. By concentrating on sustainable economic practices in the chemical industry, we can move towards a more sustainable vision of the future, Hunt said. In a letter to lead sponsor Gingrey, Hunt praised the interagency program set up by the legislation because it would strengthen the governments role as a true partner in promoting greener technologies.

Under the bill, the Nati
'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert

Page: 1 2

Related biology news :

1. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
2. Health costs soar as 60 million Americans classed as obese
3. Discovery of an American salamander where it shouldnt be: Korea
4. DNA traces evolution of extinct sabertooths and the American cheetah-like cat
5. North & South American researchers find architectural abnormalities in T. cruzi ribosome
6. T-rays: New imaging technology spotlighted by American Chemical Society
7. New peptide antibiotic isolated from American oyster
8. Computers to save unique type of American red squirrel
9. Alcoholism, smoking and genetics among Plains American Indians
10. Gene variation increases SIDS risk in African Americans
11. Americans support free access to research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)... LEADS: (top news in natural science) , Unite...ates uses less water today than it did 35 years ag...nes in water use are partly attributable to altern...icient irrigation systems. According to the latest...sed in the United States goes to cooling thermoele...
(Date:11/4/2009)...he University of Oklahoma at Norman has received m...funding agencies as part of the federal stimulus p...ng received by OU researchers to $23 million. Thi...search ranging from archaeology to weather. , "T...atic approach to matching areasof scholarly excell...
(Date:11/4/2009)..., RIDGE, N.Y., Oct. 21 What,s the...reventing accidental death resulting from prescrip...ts with good intentions, however, may be unaware t...cting their teens from the ticking timebomb of pre... leader in premium-quality medical supplies, has f...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3FamilyLife Supports Military Marriages in Milwaukee 60270 1FamilyLife Supports Military Marriages in Milwaukee 60270 2FamilyLife Supports Military Marriages in Milwaukee 60270 3FamilyLife Supports Military Marriages in Milwaukee 60270 4Blue Cross and Blue Shield of Floridas Power of the Human Voice Campaign Wins Prestigious DMA International ECHO Gold Award 60266 1Blue Cross and Blue Shield of Floridas Power of the Human Voice Campaign Wins Prestigious DMA International ECHO Gold Award 60266 2New Clues to How Fish Oils Help Arthritis Patients 60263 1New Clues to How Fish Oils Help Arthritis Patients 60263 2
...IVERSIDE, Calif. Polybrominated diphenyl ethers (...found in numerous items in the home, such as the t...s reported in a KNBC story on Nov. 28 , they are ...lood and breast milk a potentially major concern ...al chemicals have been associated with cases of fe...
...russels & Leuven, Belgium As the most common form...ease carries enormous implications for our ageing ... is caused by Alzheimer peptide (A -peptide) proto...s type of protofibril is formed and leads to the d...discovered that certain lipids, present also in ou...
...nglish chalk streams are less healthy than we thou...l warming, said Dr Mark Trimmer at a Science Media... at a plant that covers up to three quarters of th...methane generated in the sediment beneath the plan... emissions to some UK peat bogs said Dr Trimmer fr...
Other Biology News:Chemicals used as fire retardants could be harmful, UC-Riverside researchers say 2Chemicals used as fire retardants could be harmful, UC-Riverside researchers say 3Chemicals used as fire retardants could be harmful, UC-Riverside researchers say 4Lipids in the brain an important factor for Alzheimer's disease? 2
(Date:11/6/2009)... Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("...ted results from a Phase II study of intravenous R... the lung in a poster presentation at the 15th Ann...d in Miami Beach, Florida, from November 5th to 7t...tudy of Intravenous REOLYSIN (Wild-type Reovirus) ...
(Date:11/6/2009)...head’s 2010 Personalized Medicine Partnershi...ary 22-24, 2010 in Philadelphia, has been announce...key issues in forming partnerships and engage the ... Minneapolis, MN (PRWEB) Novembe...0 Personalized Medicine Partnerships Conference , ...
(Date:11/5/2009)...rstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today an...r ended September 30, 2009. GenVec reported a net ...ee months ended September 30, 2009 compared to a n...omparable quarter of 2008. For the nine months end... million ($0.15 per share), compared to a net loss...
(Date:11/5/2009)... DSM Pharmaceutical Products today announced that ... Saint Jean D,Illac, France, where DSM will be the...for Galenix commercial products on a global basis....s development opportunities co-marketing Galenix d...f Galenix in drug product development and clinical...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...ider of room-temperature biosample transport, stor...ease today of GenConnect 3.2, the newest version o... Highlights of the release include a strategic lic...ted seamlessly into third-party informatics offeri...t enables scalable enterprise-wide deployment that...
...General Meeting of Syngenta AG on 21 April 2009, t...by the Board of Directors. , , Shareholders appr...ness year 2008, an increase of 25% over the previo... the share capital to CHF 9,459,984.90 through the...ny repurchased in 2008 within the scope of the app...
...ovide sustained tumor exposure to platinum and pro...city observed in the clinic - , , DALLAS, April 2...ard: ACCP) announced today that its collaborator...preclinical data on its lead anticancer compound, ...cer Research (AACR) Annual Meeting taking place Ap...
Other Biology Technology:GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2 2GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2 3Syngenta holds Annual General Meeting 2Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting 2Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting 3Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting 4
7500 Series ICP-MS ChemStation Upgrade from Agilent Technologies
Safety Glasses Dispensers from Terra Universal, Inc.
Apparel Dispenser from Terra Universal, Inc.
...A expression profiling and built on the flexible a... platform. These microarrays are available as part...g Service. Probe Content The Mammals microRNA M... unique mature sequences). The comprehensive probe...
Biology Products: